I
Inventage Lab
Innovative microfluidics-based drug delivery systems for advanced pharmaceutical development
About Inventage Lab
Inventage Lab specializes in microfluidics-based drug delivery systems, focusing on the development and mass production of innovative pharmaceutical drugs. The company operates in the biotechnology and pharmaceutical markets, serving clients ranging from research institutions to pharmaceutical companies. Utilizing a unique platform technology, Inventage Lab designs, engineers, and optimizes drug delivery systems, including microspheres and lipid nanoparticles. Their business model revolves around joint development projects, drug re-discovery, and the production of high-quality, GMP-compliant drugs. Revenue is generated through partnerships, licensing agreements, and the sale of proprietary drug delivery systems. The company aims to advance human health by providing safe and effective treatments.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Seongnam-si, South Korea
- Sector
- Wellness Beauty
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SmileGate Investment
Series B and later12 investors entered at this stage
Mirae Asset Venture Investment
Stonebridge Ventures
IMM Investment- TMTimefolio Asset Management
- SIStarset Investment
Woori Venture Partners
Aju IB Investment
Oasis Management- BIBNH Investment
Medici Investment
Plexus Partners
DeltaFlex Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Inventage Lab on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inventage Lab on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.